Skip to content
drillr.ai
Sign up

300871.SZ

HVSEN Biotechnology Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 22.67
−2.87%
Ask drillr

  • Sep 1, 2026, 10:31 UTC

    Huisheng Biological announced that as of August 31, 2026, it had repurchased 1.3709 million shares for 30.094 million yuan under its ongoing buyback program.

    Source:

  • Aug 31, 2026, 08:48 UTC

    Huisheng Biological announced a semi-annual cash dividend of 3.00 yuan per 10 shares for 2026, totaling 60.124 million yuan, with record date September 7, 2026 and ex-dividend date September 8, 2026.

    Source:

  • Aug 14, 2026, 09:04 UTC

    Huisheng Biological announced a dividend plan: a cash dividend of 3 yuan per 10 shares (tax included) based on a base of 200 million shares (total share capital of 202 million shares minus 1.3709 million repurchased shares), with no bonus shares and no capital reserve conversion.

    Source:

  • Aug 14, 2026, 09:04 UTC

    Huisheng Biological announced its 2026 first-half results: revenue of 865 million yuan, up 5.20% year-on-year; net profit attributable to shareholders of 206 million yuan, up 75.59% year-on-year.

    Source: